Tracy Bahl Joins General Atlantic

Tracy Bahl, former CEO of Uniprise, has joined General Atlantic as a special advisor to the firm's healthcare practice. He will provide industry insight and strategic counsel to GA and its portfolio companies.



General Atlantic LLC (GA), a leading global growth equity firm, today announced that Tracy L. Bahl, former Chief Executive Officer of Uniprise, a multi-billion dollar UnitedHealth Group company, has become a Special Advisor to the firm's Healthcare sector. In this role, Mr. Bahl will provide industry expertise and strategic counsel to GA and its portfolio companies.

Founded in 1980, GA has a long history of identifying, investing in and supporting growth companies in the U.S., Europe and Asia. With a target investment size of $50 million to $500 million, GA manages approximately $15 billion and invests about $2 billion per year in growth opportunities globally. GA's investments in the Healthcare sector include current and former portfolio companies such as Emdeon, WuXi Pharmatech, Eclipsys, MultiPlan, Schaller Anderson and CompuGROUP, among others.

Jonathan Korngold, Managing Director and head of GA's Healthcare sector, noted, “We are privileged to have Tracy join the GA team and view his active involvement in our healthcare group to be an important endorsement of our efforts in the sector. Tracy's domestic and international track record will prove invaluable to GA and to our portfolio companies.”

Mr. Bahl said, “I am very excited to work with General Atlantic and believe that the firm is uniquely positioned to serve as a value-added partner to leading healthcare companies throughout the world. I look forward to being actively involved with GA's portfolio companies, as well as collaborating with the GA team to identify important industry trends on a global basis.”

In his role as CEO of Uniprise, a $6 billion division of UnitedHealth Group, Mr. Bahl was responsible for leading Uniprise's growth and for advancing the group's pre-eminent position as the leading provider of healthcare solutions to the large employer marketplace. He also led UnitedHealth Group's International business operations, including cross-border health benefits services and extensive in-country operations across the globe.

Mr. Bahl joined UnitedHealth Group in 1998 as president of domestic and multi-national employers, governments and institutions. He held this position for five years before he was named chief marketing officer of UnitedHealth Group, where he was in charge of defining and framing the corporation's marketing and business development functions. He was then appointed CEO of Uniprise in 2004.